Deucravacitinib shows superiority to placebo, apremilast in treating psoriasis
Deucravacitinib improved psoriasis compared with placebo and apremilast in a phase 3 study, Bristol Myers Squibb announced in a press
Read MoreDeucravacitinib improved psoriasis compared with placebo and apremilast in a phase 3 study, Bristol Myers Squibb announced in a press
Read MoreLebrikizumab had “generally consistent” results in improving atopic dermatitis across different races, according to results of a phase 2b study
Read MorePatients experienced a progressive improvement in rosacea after treatment with a benzoyl peroxide formulation, according to results from an extension
Read MoreCOVID-19 pandemic presents unique challenges to individuals with eating disorders Approximately 24 million people in the United States suffer from
Read MoreNot again, you may be thinking if you’ve come across the study by Zhong and colleagues, published in the March
Read MoreA controversial “dietary guidelines recommendation” published in Annals of Internal Medicine suggests that adults can continue to consume red meat
Read MoreIn chronic obstructive pulmonary disease (COPD), the benefits of pulmonary rehabilitation (PR), which are: an improvement of exercise capacity, symptoms,
Read MoreCalprotectin may serve as a blood biomarker for disease severity in patients with idiopathic pulmonary fibrosis (IPF), a new study
Read MoreIn mouse models of lung cancer and fibrosis, a combination of Esbriet (pirfenidone) and anti-PD-L1 therapy strengthened an anti-tumor immune
Read MoreOlder adults about to undergo elective surgery should undertake a sustained program of targeted exercise beforehand to counteract the muscle-wasting
Read More